It is so important that New Zealanders are able to access new, emerging and effective cancer treatments that are the standard of care in other parts...
Myeloma NZ
Rodger Tiedemann: The cancer treatments you need are available, just not in NZ
By Rodger Tiedemann 5 Sep, 2023 05:00 AM OPINION It is distressing to have to tell my cancer patients, in each and every clinic, that effective...
Father of two who’s spent his life serving the public told to consider Australia for funded cancer treatment
A Waikato police officer has been told to consider a move to Australia to treat his cancer. Will Hamilton was diagnosed with blood cancer multiple...
Bitter pill: New report finds NZ lags behind in timely access to medicines
The Shawview Report, commissioned by Johnson & Johnson, is a valuable, timely round-up of the inherent problems in our medicines funding system...
Jacq Dwyer Myeloma NZ advocate shares her story
The silken ropes holding 26 pearls around Jacq Dwyer’s neck are a beautiful reminder of her victory over a devastating illness, but one she will...
Warmest congratulations to Dr Ruth Spearing CNZM
Dr Ruth Spearing, a distinguished haematologist and medical researcher with a strong interest in CLL, has been made a Companion of the New Zealand...
NZ’s Shameful Health Secret
New Zealand sits at the bottom of the western world for access to modern medicines. Pharmac decide what drugs we buy and when. So why aren’t Kiwis...
15 year cancer thriver rides around New Zealand raising money and awareness for blood cancer multiple myeloma
American multiple myeloma patient Andrew Sninsky, 75, is cycling around New Zealand to raise awareness of a cancer without a cure. Myeloma is a...
Time taken for Pharmac funding decisions ‘too long’, says Medicines NZ
It takes the nation’s drug-buying agency, Pharmac, an average of 7.7 years to make funding decisions about potentially life-saving medicines, a...
Cancer patients harmed by ongoing treatment delays at Southern health board
In the first two months of 2021, 27 patients were harmed by cancer treatment delays, the Otago Daily Times reported. Three became so...
Therapeutic Products Bill Submission!
Myeloma New Zealand has made a submission on the Therapeutic Products Bill, as it has implications for Myeloma Patients. The Chair of the Health...
In Focus: From the lab to the clinic in New Zealand’s first CAR T-cell therapy clinical trial
Nathaniel works in the research team, where the CAR T-cells are designed, and supports both the GMP team, where the CAR T-cells are manufactured,...